Apoptosis and progression of hepatic fibrosis in hepatitis C patients
AUTOR(ES)
Schinoni, Maria Isabel, Paraná, Raymundo, Cavalcante, Daniel
FONTE
Brazilian Journal of Infectious Diseases
DATA DE PUBLICAÇÃO
2006-04
RESUMO
Hepatitis C is a worldwide endemic disease, affecting roughly 200 million people. It has a variable prognosis, depending on the progression to fibrosis. During the last five years, the importance of apoptosis for the pathogenesis of various diseases, including hepatitis, has been recognized. It has been suggested that an increase in T cell-apoptosis during a hepatitis C virus infection is the cause of impaired regulation of the immune cellular response, helping to maintain infection. Thus, the interest in discovering the probable mechanisms by which the hepatitis C virus perpetuates in the liver, and to determine the conditions that predispose for progression of this disease, makes investigation of apoptosis in hepatic injury of great interest. We have made an overview of the various mechanisms by which the cell, more specifically the hepatic cell, is affected by apoptosis, and how it interacts with the hepatitis C virus and the immune system.
Documentos Relacionados
- Fibrosis progression in chronic hepatitis C in patients coinfected with human immunodeficiency virus and hepatitis C virus
- PROGRESSION OF LIVER FIBROSIS IN MONOINFECTED PATIENTS BY HEPATITIS C VIRUS AND COINFECTED BY HCV AND HUMAN IMMUNODEFICIENCY VIRUS
- Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findings.
- Natural history of liver fibrosis progression in patients confected with hepatitis c virus and human immunodeficiency virus type 1
- Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients